Amongst other GLP-1R agonists, Exenatide uses a combination of mechanisms which may include glucose-dependent stimulation of insulin secretion, suppression of glucagon secretion, enhancement of -cell mass, slowing of gastric emptying, inhibition of food intake, and modulation of glucose trafficking in peripheral tissues (Nielsen, 2004)
People deserve access to the help GLP-1s provide I ask this as a psychologist, as a mother, as a woman getting older, and as someone who would not mind losing a few pounds
It is not approved for therapeutic use and is intended strictly for laboratory and investigative research purposes
Vascul Pharmacol (2015) 71:4056
Personal Risk Retatrutide injection site reactions are rare but may occur in anyone using this drug